Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Drug resistance mutations during structured interruptions of HAART in two HIV-1-infected children.

Current HIV research - 1 Apr 2011

Palacios-Saucedo Gerardo C, Rivera-Morales Lydia G, Vázquez-Guillén José M, Sánchez Luz M, Ramírez Teresa J, Briones Evangelina, Ortiz-López Rocío, Vázquez Carlos A, Rodríguez-Padilla Cristina

Abstract excerpt

Information concerning structured treatment interruptions (STI) of the Highly Active Antiretroviral Therapy (HAART) and their risk for selecting antiretroviral drug resistance in children is scarce. In this study, we searched for antiretroviral drug resistance mutations at the end of five viral rebounds of two children with HIV and a chronically undetectable viral load (VL) who underwent an STI program. The HAART...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Antiretroviral Therapy, Highly Active

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to CD4-CD8 Ratio

Share to Drug Resistance, Viral

Share to HIV Infections

Share to HIV Protease

Share to HIV Reverse Transcriptase

Share to Viral Load

Source

Identifiers

PMID: 21457133
DOI: 10.2174/157016211795945250

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Drug resistance mutations during structured interruptions of HAART in two HIV-1-infected children.PMID 21457133Read ↗

Mutations Related to Antiretroviral Resistance Identified by Ultra-Deep Sequencing in HIV-1 Infected Children under Structured Interruptions of HAART.Semantic proximity Read ↗

HIV-1 drug resistance genotypic profiles in children with undetectable plasma viremia during antiretroviral therapy.Semantic proximity Read ↗

Emergence of drug-resistant HIV-1 variants in patients undergoing structured treatment interruptions.Semantic proximity Read ↗

Development of HIV with drug resistance after CD4 cell count-guided structured treatment interruptions in patients treated with highly active antiretroviral therapy after dual-nucleoside analogue treatment.Semantic proximity Read ↗

Risk of selecting de novo drug-resistance mutations during structured treatment interruptions in patients with chronic HIV infection.Semantic proximity Read ↗

Immunovirologic consequences and safety of short, non-structured interruptions of successful antiretroviral treatment.Semantic proximity Read ↗

Evolution of HIV-1 genotype in plasma RNA and peripheral blood mononuclear cells proviral DNA after interruption and resumption of antiretroviral therapy.Semantic proximity Read ↗

Evolution of HIV resistance during treatment interruption in experienced patients and after restarting a new therapy.Semantic proximity Read ↗

Persistence of HIV-1 drug resistance mutations and emergence during antiretroviral treatment interruption: considerations from a clinical case.Semantic proximity Read ↗

Reversal periods and patterns from drug-resistant to wild-type HIV type 1 after cessation of anti-HIV therapy.Semantic proximity Read ↗

Lack of persistent drug-resistant mutations evaluated within and between treatment interruptions in chronically HIV-1-infected patients.Semantic proximity Read ↗

Genotypic resistance tests for the management of structured therapeutic interruptions after multiple drug failure.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.